「ME Journal」

Rakuten Medical raised $160 million in new funding

Source : “楽天メディカルが1.6億ドルを新たに調達 光免疫療法の薬剤開発、技術基盤強化に充当” issued on ME Journal Aug. 2 2021

Rakuten Medical raised $160 million in new funding
for drug development of photoimmunotherapy and enhancement of technology infrastructure

 On July 29, Rakuten Medical (Rakuten Medical, Inc.), a international biotechnology company developing and commercializing products for "photoimmunotherapy for cancer," announced that it had raised $166 million in preferred stock financing.

The funds will be used for clinical trials of the...

(Continue to the next page)

A Series of Articles

About the Author

Related Articles

No information is found.

Digital Health
U.S. eHealth Journal

Vol. 73 (Issued at 2022/09/27)

日本で医療用医薬品ネット販売を検討中と一部報道で囁かれているAmazonだが、米国ではプライマリケアプログラム「Amazon Care」向けの買収や提携を積極的に強化し、ポストコロナのハイブリッド型ケアの将来を模索している。また、公的保険制度のメディケアでは、保険償還の対象となった遠隔患者モニタリング(RPM)の利用拡大傾向が調査で明らかとなった。スタートアップ各社では、レイオフのニュースが相次いだ一方、第2四半期の決算発表を通じて、各社の次の展開が少しずつ見えてきた。

Most Popular


The First Part: Promoting Social Implementation of Genome Medicine with Information Technology, Xcoo

Dr. Shinpaku


LSMIP Editorial Office


The second part: “MyChart” One App for All Personal Health Records

Sakura Ishikawa M.D.


MSA Partners, LLC


The Second Part: iCARE, Creating the Health of Workers Around the World

Dr. Shinpaku

Press Room